Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Denosumab × Genitourinary × Clear all

Phase

Status

Sponsor Class

INDUSTRY 8 OTHER 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1

Interventions

Radiotherapy 29 bicalutamide 21 Gemcitabine 21 Docetaxel 21 Goserelin 18 Carboplatin 18 Paclitaxel 17 Cisplatin 16 Flutamide 15 Doxorubicin 15 Leuprolide 14 Radiotherapy, Conformal 10 Prednisone 10 Gene Expression Profiling 10 Filgrastim 10 Etoposide 9 Vinblastine 8 Radiotherapy, Intensity-Modulated 8 Gonadotropin-Releasing Hormone 8 Buserelin 8 Triptorelin Pamoate 7 Surgical Procedures, Operative 7 Methotrexate 7 Estramustine 7 Androgen Antagonists 7 Radiation 6 Polymerase Chain Reaction 6 Magnetic Resonance Spectroscopy 6 Ifosfamide 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03869762 2024-09-25

DICE

Cancer Trials Ireland

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡